文献速递脑血管病认知障碍与痴呆

抗抑郁药使用与抑郁与脑小血管病的关联:3C第戎磁共振成像研究

Association Between Cerebral Small Vessel Disease With Antidepressant Use and Depression: 3C Dijon Magnetic Resonance Imaging Study.
PubMed 文献 · Stroke · 2019-12-12

结果显示,非典型抗抑郁药使用者和抑郁未用药者腔隙灶风险增高,SSRI使用者和抑郁未用药者白质高信号体积更高,提示脑小血管病与抑郁及抗抑郁药暴露相关。

要点

  • 非典型抗抑郁药使用者基线及随访腔隙灶风险显著增高。
  • 抑郁未用药者基线腔隙灶风险及白质高信号体积增高。
  • SSRI使用者基线和随访深部白质高信号体积更高。

核心结论

  • 非典型抗抑郁药使用者、SSRI使用者及未用药的抑郁患者均显示脑小血管病标志物高于无抑郁/未用药组。
  • 脑小血管病与抑郁及抗抑郁药暴露相关。

研究设计与样本

  • 暴露分组:SSRI(n=68)、三环类(n=40)、非典型(n=24)、抑郁未用药(n=303)、无抑郁/未用药参照组(n=1470)。
  • 采用倾向评分校正非随机暴露。

主要发现

  • 非典型抗抑郁药使用与基线腔隙灶相关(校正率比2.59,95%CI 1.14-5.88,P=0.023)及随访腔隙灶相关(校正率比3.05,95%CI 1.25-7.43,P=0.014)。
  • 抑郁未用药者基线腔隙灶风险增高(校正率比1.53,95%CI 1.06-2.21,P=0.023)。
  • SSRI使用者和抑郁未用药者基线总、脑室旁及深部白质高信号体积更高。
  • SSRI使用者随访深部白质高信号体积更高。

临床怎么用

  • 对使用非典型抗抑郁药或SSRI的老年患者,应关注脑小血管病影像标志物。
  • 抑郁患者即使未用药,也应评估脑小血管病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Evidence links antidepressant use with cerebral small vessel disease; however, it remains unclear whether people with depression face comparable risk. This study aims to determine the association between antidepressant drug use and depression with markers of cerebral small vessel disease. Methods- One thousand nine hundred five participants (mean age, 72.5 years; 60% women) without stroke or dementia history underwent brain magnetic resonance imaging at baseline, and 1402 individuals underwent a second magnetic resonance imaging at 4 years. Outcomes were lacunes 3 to 15 mm and white matter hyperintensity volume (cm3) at baseline and follow-up. Exposure to antidepressants was grouped as (1) selective serotonin reuptake inhibitors (n=68), (2) tricyclics (n=40), (3) atypicals (n=24), (4) depressed nonusers (n=303), and (5) nondepressed/nonuser group (reference group, n=1470). Statistical analyses adjusted for propensity scores due to the nonrandomized exposure to antidepressant drugs. Results- There was an association between use of atypical antidepressants with lacunes at baseline (adjusted rate ratio, 2.59 [95% CI, 1.14-5.88]; P=0.023) and follow-up (adjusted rate ratio, 3.05 [95% CI, 1.25-7.43]; P=0.014). Lacunes at baseline were also associated with depressed nonusers (adjusted rate ratio, 1.53 [95% CI, 1.06-2.21]; P=0.023). Selective serotonin reuptake inhibitor users and depressed nonusers displayed higher total, periventricular, and deep white matter hyperintensity volumes at baseline. Selective serotonin reuptake inhibitor users had higher deep white matter hyperintensity volumes at follow-up. Conclusions- Users of atypical antidepressants, selective serotonin reuptake inhibitors, and depressed people without any antidepressant exposure all displayed markers of cerebral small vessel disease higher than the nondepressed/nonuser group. The findings suggest that cerebral small vessel disease is associated with depression and exposure to antidepressants.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Tully PJ, Alpérovitch A, Soumaré A, et al. Association Between Cerebral Small Vessel Disease With Antidepressant Use and Depression: 3C Dijon Magnetic Resonance Imaging Study. Stroke. 2019. PMID: 31826735. doi:10.1161/STROKEAHA.119.026712

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。